RxDoctor Payments Data

Jennifer Trihoulis, MD

Psychiatry · Columbia, MSNPI 1699891705

Payments from drug & device makers

$1,039in general payments, 2019–2025

Across 50 payments — averaging $20.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$322
  • Otsuka America Pharmaceutical, Inc.$246
  • Alkermes, Inc.$90
  • AbbVie$78
  • Teva Pharmaceuticals USA, Inc.$68
  • Sunovion Pharmaceuticals Inc.$52
  • plus $183 from 7 others

What the payments were for

  • Food & beverage$98695%
  • Education$535%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,039 in reported general payments places this provider in the 60th percentile of 219 psychiatry providers in Mississippi.

See all psychiatry providers in Mississippi

Medicare billing

Part B allowed, 2024
$12,132
Medicare patients
15
Services billed
149

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Wellbutrin XlBupropion Hcl12$29,745
RexultiBrexpiprazole11$18,365
TrintellixVortioxetine Hydrobromide27$18,083
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl36$10,461
VyvanseLisdexamfetamine Dimesylate17$6,211
Adderall XrDextroamphetamine/Amphetamine12$5,043
ViibrydVilazodone Hcl12$4,099
XanaxAlprazolam12$3,669
Lisdexamfetamine Dimesylate11$1,980
Quetiapine Fumarate102$1,922
Clorazepate Dipotassium14$1,731
Bupropion XlBupropion Hcl72$1,545
Desvenlafaxine Succinate ErDesvenlafaxine Succinate45$1,296
Mirtazapine62$1,271
Duloxetine Hcl103$1,269

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Takeda Pharmaceuticals U.S.A., Inc.Trintellix, Vyvanse$16$24,29444 claims
Otsuka America Pharmaceutical, Inc.Rexulti$246$18,36511 claims
AbbVieViibryd$78$4,09912 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 219 psychiatry providers in Mississippi.

Other psychiatry in Columbia

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →